Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe.

Colagrossi L;Hermans LE;Salpini R;Di Carlo D;Pas SD;Alvarez M;Ben-Ari Z;Boland G;Bruzzone B;Coppola N;Seguin-Devaux C;Dyda T;Garcia F;Kaiser R;Köse S;Krarup H;Lazarevic I;Lunar MM;Maylin S;Micheli V;Mor O;Paraschiv S;Paraskevis D;Poljak M;Puchhammer-Stöckl E;Simon F;Stanojevic M;Stene-Johansen K;Tihic N;Trimoulet P;Verheyen J;Vince A;Lepej SZ;Weis N;Yalcinkaya T;Boucher CAB;Wensing AMJ;Perno CF;Svicher V

2018